Navigation Links
Vermillion Sets First Quarter 2012 Conference Call for Tuesday, May 15, 2012 at 4:30 p.m. ET
Date:4/24/2012

AUSTIN, Texas, April 24, 2012 /PRNewswire/ -- Vermillion, Inc. (NASDAQ: VRML), a leading molecular diagnostics company, will hold a conference call on Tuesday, May 15, 2012 at 4:30 p.m. Eastern time to discuss results for the first quarter ended March 31, 2012. Financial results will be issued in a press release prior to the call.

Vermillion management will host the call, followed by a question and answer period.

Date: Tuesday, May 15, 2012
Time: 4:30 p.m. Eastern time (1:30 p.m. Pacific time)
Dial-In Number: 1-800-268-5851
International: 1-303-223-2680
Conference ID#: 21589040

The conference call will be broadcast simultaneously here and available for replay via the investor section of the company's Web site at www.vermillion.com.

Please call the conference telephone number 5-10 minutes prior to the start time. An operator will register your name and organization. If you have any difficulty connecting with the conference call, please contact Liolios Group at 1-949-574-3860.

A replay of the call will be available approximately two hours after the call and until May 29, 2012.

Toll-free replay number: 1-800-633-8284
International replay number: 1-402-977-9140
Replay pin number: 21589040

About Vermillion
Vermillion, Inc. (NASDAQ: VRML) is dedicated to the discovery, development and commercialization of novel high-value diagnostic tests that help physicians diagnose, treat and improve outcomes for patients. Vermillion, along with its prestigious scientific collaborators, has diagnostic programs in oncology, hematology, cardiology and women's health. Additional information about Vermillion can be found at www.vermillion.com.

Investor Relations:
Liolios Group, Inc.
Ron Both
Tel 949-574-3860
VRML@liolios.com

 

 


'/>"/>
SOURCE Vermillion, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Vermillion to Report Preliminary Results for Fourth Quarter and Fiscal Year 2011 on February 23, 2012
2. Vermillion Completes the Acquisition of Correlogic Systems Ovarian Cancer Diagnostics Business
3. Vermillion Reports Results for Third Quarter 2011
4. Vermillion to Present at Stephens Fall Investment Conference on November 16, 2011
5. Vermillion Engages Liolios Group to Lead Investor Relations Program
6. Vermillion Enhances Management Team With A Key Addition
7. Vermillion Appoints Distribution Partner for OVA1® in Israel and the Palestine Territories
8. Vermillion Reports Financial Results for the First Quarter 2011
9. Vermillion Announces Presentation of Positive Ovarian Biomarker Data for Next Generation Test
10. Vermillion Attends 42nd Annual Meeting of the Society of Gynecologic Oncologists
11. Vermillion to Present at the Roth 23rd Annual OC Growth Stock Conference March 13-16, 2011, Laguna Niguel, CA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2017)... Ill. , July 11, 2017  Sysmex ... and urinalysis diagnostic testing equipment as well as ... innovation: a way to make quality assurance easier ... processes. "Sysmex is well known for the innovation ... Quality Monitor elevates quality assurance processes to ...
(Date:7/11/2017)... 2017 Oramed Pharmaceuticals Inc. (NASDAQ: ... focused on the development of oral drug delivery systems, ... (FDA) has agreed to schedule an End-of-Phase II meeting ... of its oral insulin capsule ORMD-0801 in the treatment ... primary and secondary endpoints by indicating a statistically significant ...
(Date:7/10/2017)... July 10, 2017 The Institute for In ... is the recipient of a VITROCELL® inhalation exposure system ... Science Consortium. The device, which is designed to replace ... human lung cells to airborne test materials in an ... the VITROCELL® system for testing combustible tobacco products, as ...
Breaking Medicine Technology:
(Date:7/21/2017)... , ... July 21, 2017 , ... ... received a $5,000 grant from the C. R. Bard Foundation, Inc. ... at Somerset Hills , a service available through the nonprofit home care agency. ...
(Date:7/21/2017)... ... July 21, 2017 , ... In the first ... the Multicenter Orthopaedics Outcome Network (MOON) demonstrated that patients could perform sports-related functions ... activity levels decline over time. The study, presented today at the American ...
(Date:7/20/2017)... ... July 20, 2017 , ... Acute myeloid leukemia (AML) ... progresses rapidly without treatment. Newly diagnosed patients face intense chemotherapy regimens and a ... relapse. With such a challenging diagnosis that requires immediate action, patients and ...
(Date:7/20/2017)... ... 20, 2017 , ... Team Type 1 Foundation, a nonprofit organization pursuing a ... diabetes, is teaming up with a Microsoft Corp. employee-led hackathon team for the 2017 ... , “Team Type 1’s mission overlaps seamlessly with Microsoft’s mission to empower every ...
(Date:7/20/2017)... ... 2017 , ... The Dermatology Clinic announced today the addition of Dr. Scott ... from LSU, graduating summa cum laude. He attended Emory University School of Medicine in ... Louis, Dr. Dunbar moved to New York to complete an AGCME-accredited Mohs surgery fellowship ...
Breaking Medicine News(10 mins):